Latest filing published 10 Jul 2015 for Staar Surgical Co.
No signal scores available.
Based on 4 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Mark B. Logan has filed trades across 3 companies (mainly through SEC (Form 4)), most often in Vivus Inc, Staar Surgical Co and Abgenix Inc. In total, 47 filings cover trades dated from 7 March 2006 to 8 July 2015.
In open-market terms, that means 4 purchases worth €49k on one side and 10 sales worth €1.7M on the other. Sales outweigh purchases by €1.7M. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. The rest of the record consists of 8 share grants and 24 option exercises.
In size, the median ticket on the buying side is €13k. For 4 purchases whose 90-day window has closed, the share price was higher on day 90 than the day after publication in 50% of cases, with a median move of -4.0%. These figures describe past trades and do not predict future prices.
Most recently, on 10 July 2015, the filings show a share grant in Staar Surgical Co. The latest purchase dates back some time: it was published 5,090 days ago, on 16 November 2012. Typically, a trade is published a median of 2 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 46 declarations